The FDA approves oral pritelivir for drug-resistant herpes sores in immunocompromised patients; what it means for antiviral ...

As next-generation sequencing (NGS) costs gradually decline, the Food and Drug Administration’s (FDA) Division of Antiviral Products (DAVP) anticipates that more companies will make the switch to NGS ...

Pocapavir, the investigational antiviral drug studied, can allow susceptible polioviruses to sensitize resistant ones. Although this strategy seemed to work in previous lab culture studies of the ...

A team of researchers have discovered a powerful bispecific inhibitor capable of combating all existing human-pathogenic coronaviruses, including those resistant to existing treatments like Paxlovid.

Antiviral drug resistance has long been a problem in modern society. As viruses evolve, they develop resistance to antiviral drugs, which become less effective at treating diseases such as influenza.

An illustration shows a molecule nestled inside a large lumpy green mass. According to researchers' predictions, the antiviral candidate, venetoclax (red and purple), could limit SARS-CoV-2's ability ...

Viral drug resistance has emerged as a major challenge in clinical antiviral therapy. The efficacy of existing antiviral agents is frequently compromised by viral mutations, and there remains a ...

A large international team has developed a new compound that showed strong antiviral activity against HIV, including some drug-resistant variants. Despite major advances in HIV treatment, lifelong ...

A patient with chronic hepatitis B has developed resistance to lamivudine. Is it reasonable to continue lamivudine in combination with a second antiviral medication for a short period of time before ...

The US FDA on Friday approved Japan's Asahi Kasei's drug for persistent herpes simplex virus ​sores in certain patients with ...

Examining viruses' communal responses in the presence of specific challenges, such as antiviral drugs, might also help medical researchers produce more effective treatments. Pocapavir, the ...